Medtronic plc (MDT) : During the past 4 weeks, traders have been relatively bearish on Medtronic plc (MDT), hence the stock is down -0.45% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.54% relative to the S&P 500. The 4-week change in the price of the stock is -0.07% and the stock has fallen -0.57% in the past 1 week.
Medtronic plc is up 8.63% in the last 3-month period. Year-to-Date the stock performance stands at 14.3%. The stock has recorded a 20-day Moving Average of 0.4% and the 50-Day Moving Average is 0.49%.
Medtronic plc (NYSE:MDT): The stock opened at $86.77 on Friday but the bulls could not build on the opening and the stock topped out at $87.32 for the day. The stock traded down to $86.44 during the day, due to lack of any buying support eventually closed down at $87.04 with a loss of -0.05% for the day. The stock had closed at $87.08 on the previous day. The total traded volume was 5,405,005 shares.
Also, Major Brokerage house, SunTrust Robinson Humphrey maintains its ratings on Medtronic plc (NYSE:MDT). In the latest research report, SunTrust Robinson Humphrey raises the target price from $93 per share to $98 per share. According to the latest information available, the shares are now rated Buy by the analysts at the agency. The rating by the firm was issued on June 13, 2016.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.